Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654271 · ClinicalTrials.gov registry record · NA
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging
A NA study of Peripheral Pulmonary Lesion and Lung Nodule, Solitary, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 440
- Enrollment target
- 4
- Study locations
NCT06654271: Active NA study of Peripheral Pulmonary Lesion and Lung Nodule, Solitary, sponsored by Vanderbilt University Medical Center.
NCT06654271 is a NA study of Peripheral Pulmonary Lesion and Lung Nodule, Solitary that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 440 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06654271, a NA study of Peripheral Pulmonary Lesion and Lung Nodule, Solitary, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 440 participants
- Enrollment target
- 4
- Study locations
Study Summary
RELIANT 2 is a pragmatic randomized controlled trial. The goal of this study is to compare the diagnostic yield of robotic assisted bronchoscopy with integrated cone beam computed tomography to that of electromagnetic navigation bronchoscopy with integrated digital tomosynthesis in patients undergoing bronchoscopy to biopsy a pulmonary lesion.
Primary Outcome
Lesional tissue is defined by the presence of specific pathological findings that readily explain the presence of a pulmonary lesion. The following common pathological findings are pre-specified: * Malignancy * Specific benign pathologic findings including: * Organizing pneumonia * Frank purulence/robust neutrophilic inflammation * Granulomatous inflammation * Other specific benign findings such as hamartoma, amyloidoma or other uncommon causes of peripheral pulmonary lesions with dist
Conditions Studied
Interventions
- DEVICE Robotic assisted bronchoscopy (RAB)
- DEVICE Electromagnetic navigation bronchoscopy (ENB)
Study Locations (4)
Tennessee
- Vanderbilt University Medical Center - Nashville
- Vanderbilt University Medical Center - Nashville
Illinois
- Rush University Medical Center - Chicago
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2026-10-14 |
| Phase | NA |
What the registry record for NCT06654271 still lists
NCT06654271 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Peripheral Pulmonary Lesion appearing as the primary indexed condition, and to 2 interventions - of which Robotic assisted bronchoscopy (RAB) is the first listed.
NCT06654271 reports a single indexed study location in Tennessee, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT06654271 about?
NCT06654271 is a clinical study titled "Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging". RELIANT 2 is a pragmatic randomized controlled trial. The goal of this study is to compare the diagnostic yield of robotic assisted bronchoscopy with integrated cone beam computed tomography to that of electromagnetic navigation bronchoscopy with integrated digital tomosynthesis in patients undergoi...
What is the current status of trial NCT06654271?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2024-11-11. Estimated completion is 2026-10-14.
What conditions does trial NCT06654271 study?
This clinical trial studies the following conditions: Peripheral Pulmonary Lesion, Lung Nodule, Solitary.
What interventions are being tested in trial NCT06654271?
The interventions under investigation include: Robotic assisted bronchoscopy (RAB) (DEVICE), Electromagnetic navigation bronchoscopy (ENB) (DEVICE).
Who is sponsoring clinical trial NCT06654271?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06654271 being conducted?
This trial has 4 study locations across Illinois, Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06654271's enrollment target sits among peer trials
440 233rd of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI